← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2016Last known activity
Oct 31, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 2 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT05063500Lead sponsorPhase 3Oct 31, 2021
- NCT02944552Lead sponsorPhase 2Apr 1, 2016
Details
- Last known activity
- Oct 31, 2021